» Articles » PMID: 36091481

Association of Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphism with Type 1 Diabetes Mellitus: In Silico Analysis of Biological Features of CTLA-4 Protein on Ethiopian Population

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2022 Sep 12
PMID 36091481
Authors
Affiliations
Soon will be listed here.
Abstract

Background: T1DM is a chronic organ-specific T-cell-mediated autoimmune disease characterized by the selective destruction of β-cells in the islets of Langerhans, resulting in insulin deficiency and hyperglycemia. Genes for cytotoxic T lymphocyte-associated antigen 4 have been hypothesized as possible contender genes for T1DM vulnerability. However, it has not been studied in the Ethiopian population yet.

Objective: The aim of the study was to investigate CTLA-4 exon 1 was linked to A49G polymorphism with T1DM and its biological features of CTLA-4 among T1DM patients, in Ethiopia.

Methods: A case-control study was done from December 2019 to March 2020 on 210 study participants (105 T1DM patients and 105 healthy controls). Polymerase Chain Reaction amplification with forward and reverse primers was followed by restriction fragment length polymorphism and gel electrophoresis to determine gene polymorphism. Bioinformatics data of SNP was retrieved from National Centers for Biotechnology Information databases. The chi-square test and logistic regression were used. Statistical significance was defined as a P-value of less than 0.05.

Results: The CTLA-4 (+A49G) gene polymorphism was observed on 56 (26.7%) study participants, 39 (18.57%) of T1DM patients, and 17 (0.08%) were controls. In T1DM and controls, the frequency of the A allele was 73.3% and 89.5%, while the G allele was 26.7% and 10.5%, respectively. The G allele was found to be associated with T1DM (OR=3.1; 95% CI, 1.82 -5.32; P=0.001). Statistical analysis revealed an association between the likelihood of T1DM and GG genotype of the CTLA-4 (+A49G) gene polymorphism (OR=3.11; 95% CI, 1.37-10.90; P=0.01). Further in silico analyzed the SNP to assess its biological features.

Conclusion: The study showed as CTLA-4 (+A49G) gene polymorphism is linked with T1DM in the Ethiopian population.

Citing Articles

Molecular docking of curcumin and curcuminoids as human Zn dependent histone deacetylase (HDAC) enzyme inhibitors.

Anandaradje A, Kalita B, Coumar M, Selvarajan S In Silico Pharmacol. 2024; 12(1):47.

PMID: 38817777 PMC: 11133269. DOI: 10.1007/s40203-024-00221-4.


A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors.

Deligiorgi M, Trafalis D Int J Mol Sci. 2023; 24(8).

PMID: 37108792 PMC: 10146255. DOI: 10.3390/ijms24087630.


Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.

Al-Harbi N, Abdulla M, Vaali-Mohammed M, Bin Traiki T, Alswayyed M, Al-Obeed O Genes (Basel). 2023; 14(4).

PMID: 37107632 PMC: 10138150. DOI: 10.3390/genes14040874.

References
1.
Celmeli F, Turkkahraman D, Ozel D, Akcurin S, Yegin O . CTLA-4 (+49A/G) polymorphism and type-1 diabetes in Turkish children. J Clin Res Pediatr Endocrinol. 2013; 5(1):40-3. PMC: 3628391. DOI: 10.4274/Jcrpe.879. View

2.
Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T . ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016; 44(W1):W344-50. PMC: 4987940. DOI: 10.1093/nar/gkw408. View

3.
Tsega G, Getaneh G, Taddesse G . Are Ethiopian diabetic patients protected from financial hardship?. PLoS One. 2021; 16(1):e0245839. PMC: 7840028. DOI: 10.1371/journal.pone.0245839. View

4.
Balcha S, Phillips D, Trimble E . Type 1 Diabetes in a Resource-Poor Setting: Malnutrition Related, Malnutrition Modified, or Just Diabetes?. Curr Diab Rep. 2018; 18(7):47. PMC: 6002435. DOI: 10.1007/s11892-018-1003-7. View

5.
Wondemagegn A, Bizuayehu H, Abie D, Ayalneh G, Tiruye T, Tessema M . Undiagnosed Diabetes Mellitus and Related Factors in East Gojjam (NW Ethiopia) in 2016: A Community-Based Study. J Public Health Res. 2017; 6(1):834. PMC: 5402184. DOI: 10.4081/jphr.2017.834. View